Table 5.
Validation of microarray results and expression of genes of interest in relation to the factor 'n-3 LC-PUFA level'
Gene |
Low Lipid LH/LL |
High Lipid HH/HL |
||
---|---|---|---|---|
Microarray | RT-qPCR | Microarray | RT-qPCR | |
LC-PUFA biosynthesis | ||||
Δ5fad |
|
−1.19 |
|
1.17 |
Δ6fad |
|
1.13 |
|
−1.21 |
elovl2 |
|
1.14 |
|
1.06 |
Cholesterol biosynthesis | ||||
ipi |
−2.13 |
−3.92 |
−1.15 |
1.32 |
mev |
−1.54 |
−1.51 |
−1.08 |
1.06 |
7dchr |
−1.33 to −1.54 |
−1.47 |
−1.25 to −1.47 |
−1.34 |
srebp2 |
−1.72 |
−1.68 |
−1.30 |
1.60 |
Lipid transport and lipoprotein metabolism | ||||
lrp1 |
−1.14 to −3.57 |
−1.36 |
−1.39 to −1.67 |
1.24 |
apoA4a |
−1.43 |
−1.09 |
1.00 |
1.32 |
apoA4b |
−1.39 |
−1.48 |
−1.43 |
−1.10 |
lpl |
1.31 |
1.23 |
1.31 |
1.38 |
Glycerophospholipid synthesis | ||||
lpp2 |
1.20 |
−1.19 |
1.19 |
1.30 |
mgat |
1.20 |
1.04 |
1.51 |
1.78 |
Eicosanoid biosynthesis | ||||
alox5 |
1.91 |
1.48 |
1.55 |
1.62 |
pla2g4 |
1.26 |
−1.08 |
1.08 |
1.06 |
thas |
−1.33 |
−1.08 |
−1.67 |
1.34 |
ptgis |
−2.53 |
−1.25 |
−4.25 |
1.27 |
Immune response | ||||
mal |
−22.20 |
−3.70 |
−25.00 |
−5.00 |
ccl13 |
4.40 |
5.98 |
3.00 |
2.14 |
trim25 |
5.20 |
2.80 |
6.70 |
2.51 |
lect2 | 4.60 | 1.92 | 7.10 | 7.57 |
Values represent the expression ratios between high PUFA / low PUFA, for fish containing either low or high total lipid levels in their flesh, obtained by microarray analysis or RT-qPCR. Expression ratios in bold were significant by REST2008 analysis of RT-qPCR results.
Delta5 and 6 fatty acyl desaturases (Δ5fad and Δ6fad); fatty acyl elongase (elovl2); isopentenyl-diphosphate isomerase (ipi); mevalonate kinase (mev); 7-dehydrocholesterol reductase (7dchr); sterol regulatory element-binding protein 2 (srebp2); low density lipoprotein receptor-related protein 1 (lrp1); apolipoprotein A-IV (apoa4a and apoa4b); lipoprotein lipase (lpl); lipid phosphate phosphohydrolase 2 (lpp2); monoacylglycerol O-acyltransferase 1 (mgat); arachidonate 5-lipoxygenase (alox5); phospholipase A2 (pla2g4); thromboxane-A synthase (thas); prostaglandin I2 (prostacyclin) synthase (ptgis); myelin and lymphocyte protein (mal); c-c motif chemokine 13 precursor (ccl13); tripartite motif-containing protein 25 (trim25); leukocyte cell-derived chemotaxin 2 precursor (lect2).